Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             90 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A decline in the lung cancer incidence amongst men in Swedish cities 1997
16 2-3 p. 265-
1 p.
artikel
2 Adenocarcinoma of the lung — Clinical features and survival 1997
16 2-3 p. 281-
1 p.
artikel
3 β-Adrenergic signalling in neoplastic lung type 2 cells: Glucocorticoid-dependent and -independent defects 1997
16 2-3 p. 269-
1 p.
artikel
4 Analysis of thrombocytopenia due to carboplatin combined with etoposide in elderly patients with lung cancer 1997
16 2-3 p. 277-
1 p.
artikel
5 A new tumour associated antigen of non-small cell lung cancer: tumour liberated proteins (TLP)—a possible new tumor marker 1997
16 2-3 p. 271-
1 p.
artikel
6 A phase I study of a 24 hour infusion of gemcitabine in previously untreated patients with inoperable non-small-cell lung cancer 1997
16 2-3 p. 278-
1 p.
artikel
7 A prospective randomized phase III study in non-small-cell lung cancer comparing cisplatin, ifosfamide, vinbiastine (VIP) versus cisplatin, ifosfamide and etoposide (VIP-16) 1997
16 2-3 p. 279-
1 p.
artikel
8 Bombesin receptor structure and expression in human lung carcinoma cell lines 1997
16 2-3 p. 266-
1 p.
artikel
9 Bronchial muco-epidermoid carcinomas: three cases 1997
16 2-3 p. 272-273
2 p.
artikel
10 Calendar 1997
16 2-3 p. 263-264
2 p.
artikel
11 Carcinoembryonic antigen, tissue polypeptide antigen and neuron-specific enolase pleural levels used to classify small-cell and non-small-cell lung cancer patients by discriminant analysis 1997
16 2-3 p. 272-
1 p.
artikel
12 Cisplatin-etoposide combination chemotherapy for small cell lung cancer in elderly patients 1997
16 2-3 p. 276-
1 p.
artikel
13 Clinical and flow cytometric prognostic factors in surgically treated squamous cell lung cancer Kolodziejski, Leszek
1997
16 2-3 p. 173-182
10 p.
artikel
14 Comparative synchronous fluorescence spectrophotometry and 32P-postlabelling analysis of PAH-DNA adducts in human lung and the relationship to TP53 mutations 1997
16 2-3 p. 265-
1 p.
artikel
15 Defining the roles of high dose rate endobronchial brachytherapy and laser resection for recurrent bronchial malignancy Ornadel, D.
1997
16 2-3 p. 203-213
11 p.
artikel
16 Detection of amplified genomic sequences in human small-cell lung carcinoma cells by arbitrarily primed-PCR genomic fingerprinting 1997
16 2-3 p. 268-
1 p.
artikel
17 Determinants of myelosuppression in the treatment of non-small cell lung cancer with cisplatin-containing chemotherapy 1997
16 2-3 p. 277-278
2 p.
artikel
18 Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and ca 19-9 assay in pleural fluid: a study of 207 patients 1997
16 2-3 p. 271-
1 p.
artikel
19 Does the assessment of serum markers in patients with lung cancer aid in the clinical decision making process? 1997
16 2-3 p. 271-272
2 p.
artikel
20 Effect of suramin on squamous differentiation and apoptosis in three human non-small cell lung cancer cell lines 1997
16 2-3 p. 267-
1 p.
artikel
21 Effect of timing of granulocyte-colony stimulating factor administration on leukopenia induced by systemic chemotherapy in patients with non-small-cell lung cancer—Multi-center randomized crossover study 1997
16 2-3 p. 276-277
2 p.
artikel
22 Effects of interferons and tumour necrosis factor-α on human lung cancer cell lines and the development of an interferon-resistant lung cancer cell line 1997
16 2-3 p. 265-266
2 p.
artikel
23 Estimation of serum level of pS2 protein in patients with lung adenocarcinoma 1997
16 2-3 p. 271-
1 p.
artikel
24 Evaluation of radiotherapy in atelectasis secondary to lung cancer: The efficacy of palliative simple fractions at high doses 1997
16 2-3 p. 279-280
2 p.
artikel
25 Evaluation of the smoking cessation (1984–1990) therapy of the Cancer Association and Lung Association of the State of Zurich 1997
16 2-3 p. 265-
1 p.
artikel
26 Expression in human lung cancer cell lines of genes of prohormone processing and the neuroendocrine phenotype 1997
16 2-3 p. 266-
1 p.
artikel
27 Expression of peptidyl-glycine α-amidating mono-oxygenase (PAM) enzymes in morphological abnormalities adjacent to pulmonary tumors 1997
16 2-3 p. 269-270
2 p.
artikel
28 Feasibility of escalating daily doses of cisplatin in combination with accelerated radiotherapy in non-small cell lung cancer 1997
16 2-3 p. 280-281
2 p.
artikel
29 Fluorescent in situ hybridization analysis in blood lymphocytes of lung cancer patients 1997
16 2-3 p. 273-
1 p.
artikel
30 Frequent involvement of chromosome 3p alterations in lung carcinogenesis: Allelotypes of 215 established cell lines at six chromosome 3p loci 1997
16 2-3 p. 267-
1 p.
artikel
31 Full chemotherapy in elderly patients with small cell bronchial carcinoma 1997
16 2-3 p. 277-
1 p.
artikel
32 G-CSF for the prophylaxis of neutropenic fever in patients with small cell lung cancer receiving myelosuppressive antineoplastic chemotherapy: Meta-analysis and pharmaco-economic evaluation 1997
16 2-3 p. 279-
1 p.
artikel
33 Generation of human monoclonal antibodies recognising membranous antigens of the lung adenocarcinoma cell line A549 using an AMeX immunohistostaining method 1997
16 2-3 p. 274-
1 p.
artikel
34 GRP receptors are present in non small cell lung cancer cells 1997
16 2-3 p. 268-
1 p.
artikel
35 Ifosfamide-based chemotherapy for non-small cell lung cancer: Phase I/II studies at the University of Chicago 1997
16 2-3 p. 276-
1 p.
artikel
36 Immunohistochemical expression of glutathione S-transferase πι can predict chemotherapy response in patients with nonsmall cell lung carcinoma 1997
16 2-3 p. 270-
1 p.
artikel
37 Immunohistochemistry of cyclin D3 in pulmonary carcinomas 1997
16 2-3 p. 270-
1 p.
artikel
38 Inflammatory pulmonary pseudotumor in an adolescent Podbielski, Francis J.
1997
16 2-3 p. 223-227
5 p.
artikel
39 International differences in epidemiology of lung adenocarcinoma Charloux, Anne
1997
16 2-3 p. 133-143
11 p.
artikel
40 Intrapericardial cisplatin for the management of patients with large malignant pericardial effusion in the course of the lung cancer Tomkowski, Witold Z.
1997
16 2-3 p. 215-222
8 p.
artikel
41 Involvement of signal transduction pathways in lung cancer biology 1997
16 2-3 p. 266-
1 p.
artikel
42 Is the MVP regimen less active than previously described? Results of a phase II study in advanced non-small cell lung cancer 1997
16 2-3 p. 277-
1 p.
artikel
43 Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185(HER-2) in patients with systemically untreated non-small-cell lung cancer: An immunohistochemical study on cryosections 1997
16 2-3 p. 273-
1 p.
artikel
44 Late recurrence of small-cell lung cancer: Treatment and outcome 1997
16 2-3 p. 281-282
2 p.
artikel
45 Loss of heterozygosity on chromosomes 1, 11, 12 and 14 in hybrid mouse lung adenocarcinomas 1997
16 2-3 p. 269-
1 p.
artikel
46 Lung cancer and recurrent arteriovenous thrombosis 1997
16 2-3 p. 274-
1 p.
artikel
47 Lung cancer staging: the role of computed tomography and magnetic resonance imaging 1997
16 2-3 p. 272-
1 p.
artikel
48 Lung squamous cell carcinoma producing both parathyroid hormone-related peptide and granulocyte colony stimulating factor 1997
16 2-3 p. 273-
1 p.
artikel
49 Lysosomal dipeptidyl-peptidases I and II in human squamous cell lung carcinoma and lung parenchyma 1997
16 2-3 p. 270-
1 p.
artikel
50 Measurement of serum p53 protein in patients with small cell lung cancer and results of its clinicopathological evaluation Segawa, Yoshihiko
1997
16 2-3 p. 229-238
10 p.
artikel
51 Meta-analysis of the potential relationship between exposure to environmental tobacco smoke and lung cancer in nonsmoking Chinese women Wang, Tian-jue
1997
16 2-3 p. 145-150
6 p.
artikel
52 Microsatellite alteration at chromosome 3p loci in neuroendocrine and non-neuroendocrine lung tumors: histogenetic and clinical relevance 1997
16 2-3 p. 270-
1 p.
artikel
53 Monoclonal antibody αIR-3 inhibits non-small cell lung cancer growth in vitro and in vivo 1997
16 2-3 p. 268-
1 p.
artikel
54 MYC family DNA amplification in 126 tumor cell lines from patients with small cell lung cancer 1997
16 2-3 p. 267-
1 p.
artikel
55 Non-small cell lung cancer: Meta-analysis of efficacy of chemotherapy 1997
16 2-3 p. 276-
1 p.
artikel
56 Novel metastasis model of human lung cancer in SCID mice depleted of NK cells 1997
16 2-3 p. 268-269
2 p.
artikel
57 Paclitaxel plus carboplatin in advanced non-small-cell lung cancer: A phase II trial 1997
16 2-3 p. 279-
1 p.
artikel
58 Palliative endobronchial brachytherapy for central lung tumors. A prospective, randomized comparison of two fractionation schedules 1997
16 2-3 p. 280-
1 p.
artikel
59 Paraneoplastic IgA nephritis as initial symptom of a bronchial carcinoma 1997
16 2-3 p. 272-
1 p.
artikel
60 Pattern of failure and survival in endobronchial laser resection. A matched pair study 1997
16 2-3 p. 281-
1 p.
artikel
61 Pattern of mucin gene expression in normal and neoplastic lung tissues 1997
16 2-3 p. 267-268
2 p.
artikel
62 Pentoxifylline potentiates the antitumor effect of cisplatin and etoposide on human lung cancer cell lines 1997
16 2-3 p. 278-
1 p.
artikel
63 Phase II study of docetaxel (taxotere) in patients with previously untreated extensive small cell lung cancer. A trial of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) 1997
16 2-3 p. 277-
1 p.
artikel
64 Phase I trial of intravenous carboplatin added to oral etoposide and oral cyclophosphamide for stage IV non-small cell lung cancer 1997
16 2-3 p. 277-
1 p.
artikel
65 Preferential histiotypic expression of CD44-isoforms in human lung cancer Wimmel, Anja
1997
16 2-3 p. 151-172
22 p.
artikel
66 Prognostic implications of P-glycoprotein, epidermal growth factor receptor and transforming growth factor α: Immuno-histochemical expression in non-small cell lung cancer 1997
16 2-3 p. 274-
1 p.
artikel
67 Prognostic significance of tumoral angiogenesis in completely resected late stage lung carcinoma (stage IIIA-N2): Impact of adjuvant therapies in a subset of patients at high risk of recurrence 1997
16 2-3 p. 274-
1 p.
artikel
68 Quantitative immunocytochemical assays of topoisomerase II in lung adenocarcinoma cell lines—correlation to topoisomerase IIα content and topoisomerase II catalytic activity 1997
16 2-3 p. 278-279
2 p.
artikel
69 Radiochemotherapy in non-small cell lung cancer. A report of experiences 1997
16 2-3 p. 280-
1 p.
artikel
70 Radiotherapy alone vs combined chemotherapy and radiotherapy in non-resectable non-small cell lung cancer: A Phase III randomized clinical trial 1997
16 2-3 p. 280-
1 p.
artikel
71 Recent advances in the treatment of non-small cell lung cancer 1997
16 2-3 p. 281-
1 p.
artikel
72 Reduced beta adrenoceptor density in vivo in human lung tumours: a preliminary study with positron emission tomography 1997
16 2-3 p. 269-
1 p.
artikel
73 Regulation of nuclear oncogenes expressed in lung cancer cell lines 1997
16 2-3 p. 266-
1 p.
artikel
74 Relationship of early postoperative dysrhythmias and long-term outcome after resection of non-small cell lung cancer 1997
16 2-3 p. 275-
1 p.
artikel
75 Report on the 4th Central European Lung Cancer Conference Gdansk, Poland, 26–29 September 1996 Senkus-Konefka, Elźbieta
1997
16 2-3 p. 259-262
4 p.
artikel
76 Resection of single brain metastasis in non-small-cell lung cancer: prognostic factors 1997
16 2-3 p. 275-
1 p.
artikel
77 Serum levels of interleukin-10 and interleukin-6 in patients with lung cancer 1997
16 2-3 p. 273-274
2 p.
artikel
78 Steroid-hormone receptors in cell lines and tumor biopsies of human lung cancer 1997
16 2-3 p. 267-
1 p.
artikel
79 Superiority of cisplatin or carboplatin in combination with teniposide and vincristine in the induction chemotherapy of small-cell lung cancer. A randomized trial with 5 years follow up 1997
16 2-3 p. 278-
1 p.
artikel
80 Surgical treatment of 125 patients with non-small cell lung cancer and chest wall involvement 1997
16 2-3 p. 275-
1 p.
artikel
81 Synchronous lung carcinomas of different histology within the same lobe 1997
16 2-3 p. 272-
1 p.
artikel
82 Ten-year survival after resection for lung carcinoma 1997
16 2-3 p. 276-
1 p.
artikel
83 The diagnostic role of 201T1 SPET imaging in patients with lung tumours: Comparison with computed tomography 1997
16 2-3 p. 275-
1 p.
artikel
84 The relationship between digital clubbing and serum growth hormone level in patients with lung cancer 1997
16 2-3 p. 274-
1 p.
artikel
85 The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: a comparative study with X-ray computed tomography 1997
16 2-3 p. 273-
1 p.
artikel
86 5th I.A.S.L.C. Lung Tumor Biology Workshop, August 13–17, 1996, Ermatingen, Switzerland Bunn, P.
1997
16 2-3 p. 239-257
19 p.
artikel
87 Thoracoscopic evaluation of histologically/cytologically proven or suspected lung cancer: a VATS exploration Asamura, Hisao
1997
16 2-3 p. 183-190
8 p.
artikel
88 Transferrin dependence of Ga (NO3)3 inhibition of growth in human-derived small cell lung cancer cells 1997
16 2-3 p. 268-
1 p.
artikel
89 ‘Tumour volume’ as a predictor of survival after resection of non-small-cell lung cancer (NSCLC) 1997
16 2-3 p. 275-276
2 p.
artikel
90 Usefulness of longitudinal evaluation of Cyfra 21-1 variations in advanced lung cancer monitoring Hamzaoui, A.
1997
16 2-3 p. 191-202
12 p.
artikel
                             90 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland